Market Cap 12.59M
Revenue (ttm) 2.29M
Net Income (ttm) -18.63M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -813.54%
Debt to Equity Ratio 0.47
Volume 65,400
Avg Vol 71,778
Day's Range N/A - N/A
Shares Out 3.02M
Stochastic %K 52%
Beta -2.13
Analysts Strong Sell
Price Target $60.00

Company Profile

Femasys Inc., a biomedical company, develops and commercializes therapeutic and diagnostic products for women's reproductive health needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination device; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemSperm, a sperm handling kit; FemChec, a confirmation test for tubal patency; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; and FemCath, a cornual b...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 770 500 3910
Fax: 404 581 5903
Website: femasys.com
Address:
3950 Johns Creek Court, Suite 100, Suwanee, United States
Bluesir
Bluesir Jul. 4 at 4:46 PM
$FEMY "Cash and cash equivalents as of March 31, 2026, was approximately $5.4 million and the Company had an accumulated deficit of approximately $145.0 million. The Company expects, based on its current operating plan, its current cash and cash equivalents will be sufficient to fund its ongoing operations into the third quarter of 2026." I took the risk and bought back on Thursday. Just curious to see where they get the finance they urgently need. There's a lot of outstandings warrants but with ex. price is from $16 to 22 (after R/S). They could renegotiate the ex. price, as to avoid a new offering, or send the SP "to the moon" with or without a great news. Anything has to be decided in the next days. Be prepared for a very high volatily. GLA
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:38 PM
1 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
$FEMY if you are nt buying back into this, You are nutz.
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:14 PM
0 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jul. 2 at 5:00 PM
$FEMY Let’s see $7 then $10. Price can raise just as much as it irrationally went down.
0 · Reply
MIKEMB
MIKEMB Jul. 2 at 2:58 PM
$FEMY good news in the air.....
1 · Reply
Latest News on FEMY
Femasys regains compliance with Nasdaq

2026-06-24T13:15:18.000Z - 10 days ago

Femasys regains compliance with Nasdaq


Femasys Regains Compliance with Nasdaq Listing Requirements

Jun 24, 2026, 9:00 AM EDT - 10 days ago

Femasys Regains Compliance with Nasdaq Listing Requirements


Femasys Inc trading halted, news pending

2026-06-05T23:55:32.000Z - 4 weeks ago

Femasys Inc trading halted, news pending


Femasys announces CE Mark approval for FemHSG Catheter

2026-05-13T14:46:53.000Z - 7 weeks ago

Femasys announces CE Mark approval for FemHSG Catheter


Femasys Slides: Corporate presentation

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Femasys Slides: Corporate presentation


Femasys Quarterly report: Q1 2026

May 8, 2026, 8:00 AM EDT - 2 months ago

Femasys Quarterly report: Q1 2026


Femasys Earnings release: Q1 2026

May 8, 2026, 8:00 AM EDT - 2 months ago

Femasys Earnings release: Q1 2026


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Femasys Annual report: Q4 2025


Femasys Earnings release: Q4 2025

Mar 31, 2026, 8:00 AM EDT - 3 months ago

Femasys Earnings release: Q4 2025


Femasys Proxy statement: Proxy filing

Mar 27, 2026, 8:00 AM EDT - 3 months ago

Femasys Proxy statement: Proxy filing


Femasys management to meet virtually with Lake Street

2026-03-24T15:20:53.000Z - 3 months ago

Femasys management to meet virtually with Lake Street


Femasys appoints Kenneth Eichenbaum to its Board of Directors

2026-03-18T13:05:27.000Z - 3 months ago

Femasys appoints Kenneth Eichenbaum to its Board of Directors


Femasys initiated with a Buy at Lake Street

2026-03-03T13:13:48.000Z - 4 months ago

Femasys initiated with a Buy at Lake Street


Femasys FemBloc achieved certification under MDSAP

2026-02-26T14:06:51.000Z - 4 months ago

Femasys FemBloc achieved certification under MDSAP


Femasys enters distribution partnership with OR Consulting

2026-02-03T14:20:28.000Z - 5 months ago

Femasys enters distribution partnership with OR Consulting


Femasys announces partnership with Refuah Health Center

2026-01-13T14:05:24.000Z - 6 months ago

Femasys announces partnership with Refuah Health Center


Femasys files to sell 68.42M shares of common stock for holders

2025-12-31T21:40:10.000Z - 6 months ago

Femasys files to sell 68.42M shares of common stock for holders


Femasys Registration statement: Registration filing

Dec 31, 2025, 7:00 AM EST - 6 months ago

Femasys Registration statement: Registration filing


Femasys secures U.S. FDA clearance for FemVue Controlled device

2025-12-18T14:21:29.000Z - 7 months ago

Femasys secures U.S. FDA clearance for FemVue Controlled device


Femasys Registration statement: Registration filing

Dec 4, 2025, 7:00 AM EST - 7 months ago

Femasys Registration statement: Registration filing


Femasys initiated with a Buy at Laidlaw

2025-11-20T10:00:27.000Z - 8 months ago

Femasys initiated with a Buy at Laidlaw


Femasys Quarterly report: Q3 2025

Nov 14, 2025, 7:00 AM EST - 8 months ago

Femasys Quarterly report: Q3 2025


Femasys Earnings release: Q3 2025

Nov 14, 2025, 7:00 AM EST - 8 months ago

Femasys Earnings release: Q3 2025


Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Oct 16, 2025, 9:00 AM EDT - 9 months ago

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo


Femasys Registration statement: Registration filing

Aug 21, 2025, 8:00 AM EDT - 11 months ago

Femasys Registration statement: Registration filing


Femasys Registration statement: Registration filing

Aug 20, 2025, 8:00 AM EDT - 11 months ago

Femasys Registration statement: Registration filing


Femasys Announces Second Quarter Financial Results for 2025

Aug 8, 2025, 4:05 PM EDT - 11 months ago

Femasys Announces Second Quarter Financial Results for 2025


Femasys Quarterly report: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Femasys Quarterly report: Q2 2025


Femasys Earnings release: Q2 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Femasys Earnings release: Q2 2025


Femasys Registration statement: Registration filing

Jul 3, 2025, 8:00 AM EDT - 1 year ago

Femasys Registration statement: Registration filing


Femasys Quarterly report: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Quarterly report: Q1 2025


Femasys Earnings release: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q1 2025


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Proxy statement: Proxy filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Femasys Proxy statement: Proxy filing


Femasys Annual report: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Annual report: Q4 2024


Femasys Earnings release: Q4 2024

Mar 27, 2025, 8:00 AM EDT - 1 year ago

Femasys Earnings release: Q4 2024


Femasys Quarterly report: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Quarterly report: Q3 2024


Femasys Earnings release: Q3 2024

Nov 12, 2024, 7:00 AM EST - 1 year ago

Femasys Earnings release: Q3 2024


Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

Aug 27, 2024, 8:30 AM EDT - 2 years ago

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters


Femasys Quarterly report: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q2 2024


Femasys Earnings release: Q2 2024

Aug 8, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q2 2024


Femasys Proxy statement: Proxy filing

Jun 7, 2024, 8:00 AM EDT - 2 years ago

Femasys Proxy statement: Proxy filing


Femasys Quarterly report: Q1 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Femasys Quarterly report: Q1 2024


Femasys Earnings release: Q1 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Femasys Earnings release: Q1 2024


Bluesir
Bluesir Jul. 4 at 4:46 PM
$FEMY "Cash and cash equivalents as of March 31, 2026, was approximately $5.4 million and the Company had an accumulated deficit of approximately $145.0 million. The Company expects, based on its current operating plan, its current cash and cash equivalents will be sufficient to fund its ongoing operations into the third quarter of 2026." I took the risk and bought back on Thursday. Just curious to see where they get the finance they urgently need. There's a lot of outstandings warrants but with ex. price is from $16 to 22 (after R/S). They could renegotiate the ex. price, as to avoid a new offering, or send the SP "to the moon" with or without a great news. Anything has to be decided in the next days. Be prepared for a very high volatily. GLA
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:38 PM
1 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 2 at 7:37 PM
$FEMY if you are nt buying back into this, You are nutz.
0 · Reply
StreakGeek
StreakGeek Jul. 2 at 5:14 PM
0 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jul. 2 at 5:00 PM
$FEMY Let’s see $7 then $10. Price can raise just as much as it irrationally went down.
0 · Reply
MIKEMB
MIKEMB Jul. 2 at 2:58 PM
$FEMY good news in the air.....
1 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 1 at 7:48 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 1 at 7:48 PM
0 · Reply
NEWBIGTECH
NEWBIGTECH Jul. 1 at 7:46 PM
$FEMY own it.
0 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jul. 1 at 7:30 PM
$FEMY Looking better and better. Let’s see double digits — then we’ll be at least rolling onto the runway.
0 · Reply
Zaksab
Zaksab Jul. 1 at 7:19 PM
$FEMY anyone here who is getting wet should donate to the company they might be able to sell it with their plastic straw
0 · Reply
dongknotts
dongknotts Jul. 1 at 6:08 PM
$FEMY Looks like this is finally starting to move after the 50% drop related to the revers split. Any thoughts on where this is heading?
0 · Reply
ididathing9999
ididathing9999 Jul. 1 at 3:44 PM
$FEMY c'mon let's go, $100 mill buyout @ $33 / share and pack it in, call it a day! This figure is not real money for all the multi-billion dollar medical device companies out there. They could even broker an all-stock deal that would cost them nothing out of pocket! Abbott with its $161 billion market cap could print 1 mill shares (worth 93 mill) out of thin air like its nothing. But obviously expecting to get 1 ABT for 3 FEMY is a completely absurd proposition. As they say in this space right now, there's a growing disparity between the haves and the have nots...
0 · Reply
SenshiD
SenshiD Jun. 30 at 10:10 PM
1 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jun. 30 at 5:06 PM
$FEMY Probably insiders loading thr boat. They know the porfolio / tech is worth ming’s randsome. The MC had gotten ridiculous, especially with the buyiut prospects.
0 · Reply
cjw1979
cjw1979 Jun. 30 at 4:17 PM
$FEMY someone urgently market ordered $ 100K worth of shares this morning. Interesting.
0 · Reply
MultiversalTruth
MultiversalTruth Jun. 30 at 3:06 PM
$FEMY I asked Grok a bit more about Fembloc’s future market potential and how it translates to share price. Albeit, this is some time off, but ground floor is where I want to be. Conservative Scenario: Target of $70 Million Revenue If FemBloc captures 5% of the U.S. market and hits $70 million in revenue: New Market Cap: $280 million ($70M revenue 4x multiple) Resulting Share Price: $94.59 per share Without any further dilution, a $280 million market cap would equal a $92.73 share price. However, factoring in historical fundraising trends: • Moderate Dilution (Shares double to ~6M): The projected share price drops to $46.67. • Severe Dilution (Shares triple to ~9M): The projected share price drops to $31.11. • Extreme Long-Term Historical Trajectory (164M Shares by 2031): If Femasys continues to expand its float matching its peak historical velocity to fund commercial scaling, the projected share price drops to $1.70. ..
6 · Reply
4RiskyBusiness4
4RiskyBusiness4 Jun. 29 at 8:00 PM
$FEMY Looking like a good call so far. 😁
1 · Reply